veratridine has been researched along with antillatoxin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Lera Ruiz, M; Kraus, RL | 1 |
| Cao, Z; Gerwick, WH; Murray, TF | 1 |
1 review(s) available for veratridine and antillatoxin
| Article | Year |
|---|---|
Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications.
Topics: Animals; Biological Products; Cardiovascular Diseases; Channelopathies; Clinical Trials as Topic; Drug Industry; Epilepsy; Humans; Ion Channel Gating; Ligands; Mutation; Neoplasms; Neuromuscular Diseases; Pain; Protein Structure, Tertiary; Protein Subunits; Respiratory Tract Diseases; Voltage-Gated Sodium Channel Blockers; Voltage-Gated Sodium Channels | 2015 |
1 other study(ies) available for veratridine and antillatoxin
| Article | Year |
|---|---|
Antillatoxin is a sodium channel activator that displays unique efficacy in heterologously expressed rNav1.2, rNav1.4 and rNav1.5 α subunits.
Topics: Animals; Benzofurans; Calcium; Calcium Signaling; Cell Line; Cell Membrane; Dose-Response Relationship, Drug; Ion Channel Gating; Lipopeptides; Marine Toxins; Muscle Proteins; NAV1.2 Voltage-Gated Sodium Channel; NAV1.5 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Peptides, Cyclic; Protein Subunits; Sodium Channels; Veratridine | 2010 |